Stephani L Stancil
Overview
Explore the profile of Stephani L Stancil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stancil S, Brewe M, Tumberger J, Bartkoski M, Burns A, Yeh H, et al.
Contemp Clin Trials
. 2025 Mar;
152:107874.
PMID: 40043750
Eating disorders (ED) affect 5 % of youth, are associated with reward system alterations, and lead to substantial morbidity. Naltrexone, an opioid antagonist, is used to treat ED behaviors such...
2.
Bartkoski M, Tumberger J, Martin L, Choi I, Lee P, Strawn J, et al.
Paediatr Drugs
. 2025 Feb;
PMID: 39899194
Neuroimaging, specifically magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and positron emission tomography (PET), plays an important role in improving the therapeutic landscape of pediatric neuropsychopharmacology by detecting target...
3.
Stimpfl J, Walkup J, Robb A, Alford A, Stahl S, McCracken J, et al.
J Child Adolesc Psychopharmacol
. 2024 Oct;
35(1):3-22.
PMID: 39469761
Antidepressant medications, including selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), are commonly used to treat depressive, anxiety, and obsessive-compulsive disorders in youth. Yet, data on discontinuing these...
4.
Miller M, Goggin K, Stancil S, Miller E, Ketterer T, Staggs V, et al.
Acad Emerg Med
. 2024 Jun;
31(11):1100-1111.
PMID: 38881403
Background: This study assessed feasibility constructs of adolescent contraceptive care in the pediatric emergency department (PED), including contraception initiation. Methods: We conducted a randomized trial in two PEDs with pregnancy-capable...
5.
Stancil S, Sandritter T, Strawn J
J Child Adolesc Psychopharmacol
. 2024 Feb;
34(1):61-66.
PMID: 38377523
Oxcarbazepine is thought to be better-tolerated and less susceptible to drug-drug interactions than its predecessor, carbamazepine. Genetic testing for *15:02 is recommended in specific populations to identify those at high...
6.
Stancil S, Pearce R, Staggs V, Leeder J
Drug Metab Dispos
. 2023 Sep;
51(12):1578-1582.
PMID: 37735064
Scaling factors are necessary for translating in vitro drug biotransformation data to in vivo clearance values in physiologically-based pharmacokinetic modeling and simulation. Values for microsomal protein per gram of liver...
7.
Stancil S, Yeh H, Brucks M, Bruce A, Voss M, Abdel-Rahman S, et al.
Front Psychiatry
. 2023 Jul;
14:1161032.
PMID: 37492067
Background: Eating Disorders (ED) affect up to 5% of youth and are associated with reward system alterations and compulsive behaviors. Naltrexone, an opioid antagonist, is used to treat ED behaviors...
8.
Stancil S, Voss M, Nolte W, Tumberger J, Adelman W, Abdel-Rahman S
Clin Transl Sci
. 2022 Oct;
15(11):2732-2743.
PMID: 36200172
Naltrexone (NTX), an opioid antagonist metabolized by aldo-keto reductase 1C4 (AKR1C4), is prescribed for psychiatric conditions like eating disorders with variable response. Systemic exposure is highly variable in adults, yet...
9.
Stancil S, Tumberger J, Strawn J
Clin Transl Sci
. 2021 Dec;
15(4):816-823.
PMID: 34913258
The current pediatric mental health crisis is characterized by staggering rates of depression, anxiety, and suicide. Beyond this, first-line pharmacologic interventions for depressive and anxiety disorders in children and adolescents...
10.
Stancil S, Nolte W, Pearce R, Staggs V, Leeder J
Drug Metab Dispos
. 2021 Nov;
50(2):168-173.
PMID: 34728519
Naltrexone, an opioid antagonist primarily metabolized by aldo-keto reductase 1C4 (AKR1C4), treats pediatric conditions involving compulsiveness (e.g., autism spectrum, Prader-Willi, eating disorders, non-suicidal self-injury). Pharmacokinetic variability is apparent in adults,...